Regulation of BzATP ‐Induced Blood–Brain Barrier Endothelial Cell Hyperpermeability by NLRP3 Inflammasome Inhibition
Microcirculation · 2025
DOI: 10.1111/micc.70006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microcirculation, 2025. Verfasst von Aliyah Anderson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Morehouse School of Medicine, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Blood-Brain Barrier, Inflammasomes, Endothelial Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Objective
The blood–brain barrier (BBB) is a semi‐permeable microvascular barrier, composed of endothelial cells conjoined by tight junction proteins. Following pathological conditions, i.e., traumatic brain injury (TBI), BBB dysfunction occurs, leading to microvascular hyperpermeability, resulting in cerebral edema formation and elevated intracranial pressure. Recent evidence suggests that the activation of pro‐inflammatory signaling pathways is critical to BBB dysfunction. The NLRP3 inflammasome has been implicated as a key component of pro‐inflammatory signaling. The aim of this study was to determine the upstream regulators of NLRP3 inflammasome activation that cause subsequent BBB aberration and microvascular hyperpermeability.
Methods
Brain microvascular endothelial cells were exposed to benzoyl ATP (BzATP) with or without MCC950. We employed immunocytochemical localization of tight junction proteins, fluorometric enzymatic assays, total gene expression analyses of ZO‐1, and monolayer permeability studies to assess the effect of BzATP‐induced injury on NLRP3 inflammasome activation/inhibition.
Results
BzATP treatment induced monolayer hyperpermeability and increased caspase‐1 and MMP‐9 activities. NLRP3 inhibition decreased caspase‐1 and MMP‐9 activities and rescued BzATP‐induced monolayer permeability significantly.
Conclusions
NLRP3 inflammasome signaling is critical to BBB endothelial cell dysfunction. Extracellular ATP is an upstream promoter of BBB hyperpermeability. NLRP3 inflammasome activation leads to subsequent caspase‐1 and MMP‐9‐mediated tight junction protein disarray.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Morehouse School of Medicine, Atlanta, Georgia, USA.
ORCID-Profile: Aliyah Anderson
Förderung
- NIGMS NIH HHS
- NINDS NIH HHS
- NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
Zitieren
APA
Anderson, A., Waithe, O. Y., Seplovich, G., Olagunju, O., Greene, C., Singh, A., Muthusamy, S., & Tharakan, B. (2025). Regulation of BzATP ‐Induced Blood–Brain Barrier Endothelial Cell Hyperpermeability by NLRP3 Inflammasome Inhibition. Microcirculation. https://doi.org/10.1111/micc.70006
Vancouver
Anderson A, Waithe OY, Seplovich G, Olagunju O, Greene C, Singh A, et al. Regulation of BzATP ‐Induced Blood–Brain Barrier Endothelial Cell Hyperpermeability by NLRP3 Inflammasome Inhibition. Microcirculation. 2025. doi:10.1111/micc.70006
BibTeX
@article{Anderson2025,
author = {Anderson, Aliyah and Waithe, O'lisa Yaa and Seplovich, Gabriela and Olagunju, Oluwatoyin and Greene, Christlyn and Singh, Amrendra and Muthusamy, Saravanakumar and Tharakan, Binu},
title = {Regulation of BzATP ‐Induced Blood–Brain Barrier Endothelial Cell Hyperpermeability by NLRP3 Inflammasome Inhibition},
journal = {Microcirculation},
year = {2025},
doi = {10.1111/micc.70006}
}
EUVIMED